High-grade Neuroendocrine Neoplasm

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating lurbinectedin in combination with berzosertib (an ATR kinase inhibitor) for small cell cancers and high-grade n…

• CLINICAL_TRIALS research · 2025-12-17
  Clinical Trial Update: Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs) [Phase 2]

  This document reports that Zanzalintinib is being evaluated as maintenance therapy in high-grade neuroendocrine neoplasms in a Phase 2 trial…